Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma

被引:2
|
作者
Bajestani, Nojan [1 ]
Wu, Gavin [1 ]
Hussein, Ahmed [1 ]
Makary, Mina S. [2 ]
机构
[1] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Dept Radiol, Div Vasc & Intervent Radiol, 395 W 12th Ave, Columbus, OH 43210 USA
关键词
hepatocellular carcinoma; locoregional therapy; immunotherapy; combination therapy; progression-free survival; overall survival; PERCUTANEOUS RADIOFREQUENCY ABLATION; INTERNAL RADIATION-THERAPY; RANDOMIZED CONTROLLED-TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; OPEN-LABEL; PHASE-III; SURGICAL RESECTION; MICROWAVE ABLATION; Y-90; MICROSPHERES; SYSTEMIC THERAPY;
D O I
10.3390/biomedicines12071432
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
More than 800,000 people worldwide are diagnosed with HCC (hepatocellular carcinoma) each year, with approximately 700,000 deaths alone occurring in that same year. Treatment of HCC presents complex therapeutic challenges, particularly in intermediate and advanced stages. LRTs such as transarterial chemoembolization (TACE) and ablations have been the mainstay treatment for early to intermediate-stage HCC, and systemic therapies are used to treat intermediate-late-stage HCC. However, novel literature describing combining LRT with systemic therapies has shown promising results. This review explores recent advances in both liver-directed techniques for hepatocellular carcinoma, including bland transarterial embolization, chemoembolization, radioembolization, and ablative therapies in conjunction as well as with systemic therapies, with a focus on combination therapies, patient selection, procedural technique, periprocedural management, and outcomes. Our findings suggest that LRT combined with systemic therapies is a viable strategy for improving progression-free survival and time to progression for patients with intermediate-to-late-stage HCC. However, further investigation is required to refine treatment protocols and define patient cohorts that would benefit the most.
引用
收藏
页数:30
相关论文
共 50 条
  • [1] Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
    Jian Xue
    Hongbo Ni
    Fan Wang
    Ke Xu
    Meng Niu
    Journal of Interventional Medicine, 2021, 4 (03) : 105 - 113
  • [2] Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions
    Dendy, Meaghan S.
    Ludwig, Johannes M.
    Stein, Stacey M.
    Kim, Hyun S.
    LIVER CANCER, 2019, 8 (05) : 326 - 340
  • [3] Locoregional Therapy for Hepatocellular Carcinoma
    Guimaraes, Marcelo
    Uflacker, Renan
    CLINICS IN LIVER DISEASE, 2011, 15 (02) : 395 - +
  • [4] Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies
    Liu, Qi
    Zhang, Renjie
    Shen, Weixi
    EJSO, 2025, 51 (02):
  • [5] How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
    Fu, Yan
    Zeng, Chu Hui
    An, Chao
    Liu, Yue
    Shin, Ji Hoon
    Li, Xiao
    CANCERS, 2023, 15 (04)
  • [6] Locoregional Therapy of Hepatocellular Carcinoma
    Habib, Ali
    Desai, Kush
    Hickey, Ryan
    Thornburg, Bartley
    Lewandowski, Robert
    Salem, Riad
    CLINICS IN LIVER DISEASE, 2015, 19 (02) : 401 - +
  • [7] Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
    Podlasek, Anna
    Abdulla, Maheeba
    Broering, Dieter
    Bzeizi, Khalid
    CANCERS, 2023, 15 (13)
  • [8] Issue on combined locoregional and systemic treatment for hepatocellular carcinoma
    Wu, Yi-Chia
    Wakil, Ali
    Salomon, Fayssa
    Pyrsopoulos, Nikolaos
    HEPATOMA RESEARCH, 2023, 9
  • [9] Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
    Makary, Mina S.
    Khandpur, Umang
    Cloyd, Jordan M.
    Mumtaz, Khalid
    Dowell, Joshua D.
    CANCERS, 2020, 12 (07) : 1 - 18
  • [10] The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
    Brandi, Nicolo
    Renzulli, Matteo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)